Evidence map›Paper›PMID 30476179›Full record

ArticleThe Journal of clinical endocrinology and metabolism2019

Impact of Route of Estrogen Administration on Bone Turnover Markers in Oligoamenorrheic Athletes and Its Mediators.

Vibha Singhal, Kathryn E Ackerman, Amita Bose, Landy Paola Torre Flores, Hang Lee, Madhusmita Misra

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Effects of Estrogen Replacement on Bone Geometry and Microarchitecture in Adolescent and Young Adult Oligoamenorrheic Athletes: A Randomized Trial.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020
    Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. The female athlete triad: review of current literature.Current opinion in endocrinology, diabetes, and obesity · 2022
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Vibha SinghalNeuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Kathryn E AckermanNeuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Amita BoseNeuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Landy Paola Torre FloresNeuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Hang LeeBiostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Madhusmita MisraNeuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Harvard University · USBoston Children's Hospital · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MARTIN TORRIANI · 1994 to 2026
$31.6M
Fat Mediated Modulation of Reproductive and Endocrine Function in Young AthletesR01HD060827 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI MISRA, MADHUSMITA · 2009 to 2013
$2.4M
Determinants of Beta Cell Function Following Sleeve Gastrectomy in AdolescentsK23DK110419 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI SINGHAL, VIBHA · 2016 to 2021
$1.1M
Bone Metabolism and Body Composition in Young AthletesK24HD071843 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI MISRA, MADHUSMITA · 2013 to 2017
$930k
NCATS NIH HHS UL1 TR001102NICHD NIH HHS K24 HD071843NICHD NIH HHS R01 HD060827NIDDK NIH HHS K23 DK110419NIDDK NIH HHS P30 DK040561
6 · The paper itself

Abstract

objectiveTransdermal, but not oral, estrogen replacement improves bone mineral density (BMD) in athletes with oligoamenorrhea (OA). Our objective was to determine mechanisms that may explain the impact of route of estrogen administration on bone outcomes.

methodsSeventy-three participants with OA between 14 and 25 years old received (i) a 17β-estradiol transdermal patch continuously with cyclic oral micronized progesterone (PATCH), (ii) a combined ethinyl estradiol and desogestrel pill (PILL), or (iii) no estrogen/progesterone (NONE) for 12 months. We evaluated morning fasting levels of a marker of bone formation [N-terminal propeptide of type 1 procollagen (P1NP)], a marker of bone resorption (N-telopeptide), IGF-1, insulinlike growth factor binding protein 3, total testosterone, estradiol, SHBG, sclerostin, preadipocyte factor-1 (Pref-1), brain-derived neurotrophic factor (BDNF), calcium, 25(OH) vitamin D, and PTH levels at baseline and 12 months.

resultsGroups did not differ for age, weight, exercise activity, or markers of bone formation at baseline. Over 12 months, P1NP decreased the most in the PILL group (P = 0.03) associated with a decrease in IGF-1 levels (r = 0.37; P = 0.003). Sclerostin, Pref-1, and BDNF decreased in the PATCH group over 12 months. PATCH had the greatest increases in estradiol (P ≤ 0.0001), and estradiol increases were associated with increases in bone density.

conclusionTransdermal 17β-estradiol given over 12 months does not cause the decrease in IGF-1 observed with oral ethinyl estradiol. It also leads to decreases in sclerostin, Pref-1, and BDNF, which may mediate the beneficial effects of estrogen.

Indexed as

AdolescentAdultAthletesBiomarkersBone DensityBone RemodelingBone ResorptionDrug Administration RoutesEstrogensFemaleFollow-Up StudiesHumansOligomenorrheaYoung AdultBiomarkersEstrogens

Identifiers

PMID30476179
PMCPMC6435214
OpenAlexW2901699389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.